Upstream Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Upstream Bio, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Revenue & Gross Profit
Revenue2.372.381.21
Cost of Revenue0.000.000.00
Gross Profit2.372.381.21
Operating Expenses
Research & Development62.9731.8018.66
Selling, General & Administrative17.1710.706.46
Operating Expenses80.1342.4925.12
Operating Income-77.76-40.11-23.91
Other Income/Expense
Interest Income12.124.170.21
Interest Expense0.000.000.00
Other Income/Expense2.8415.41-0.16
Income
Income Before Tax-62.81-20.54-23.87
Income Tax Expense0.000.000.00
Net Income-62.81-20.54-23.87
Net Income - Continuous Operations-62.81-20.54-23.87
Net Income - Discontinued Operations0.000.000.00
EBITDA-77.68-40.05-23.90
EBIT-77.76-40.11-23.91
Depreciation & Amortization0.090.060.01
Earnings Per Share
Basic EPS-1.00-1.00-1.00
Diluted EPS-1.00-1.00-1.00
Basic Shares Outstanding53.6036.3236.32
Diluted Shares Outstanding53.6036.3236.32